Invesco India Financial Services Fund vs Invesco India Pharma and Healthcare Fund
Direct Plan, Growth option · Data as on 30-10-2026
Invesco India Financial Services Fund is a Sectoral fund and Invesco India Pharma and Healthcare Fund is a Sectoral fund. Invesco India Financial Services Fund charges 0.96% a year and Invesco India Pharma and Healthcare Fund 3.30% (Direct plans). Their portfolios overlap 0.0%: they hold 0 of the same securities.
Invesco India Financial Services Fund
Sectoral
- Expense ratio
- 0.96%
- NAV
- ₹166.82
Invesco India Pharma and Healthcare Fund
Sectoral
- Expense ratio
- 3.30%
- NAV
- ₹9.66
Which is better, Invesco India Financial Services or Invesco India Pharma and Healthcare? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Invesco India Financial Services costs less: 0.96% a year against 3.30% (Direct plans).
- Invesco India Financial Services fell less in its worst fall since 10-09-2026: −7.3% against −11.4%.
- Invesco India Financial Services holds more in large companies: 53.8% of the fund in large caps against 29.8%.
- Invesco India Financial Services is the larger fund: ₹1,789 Cr against ₹436 Cr.
- Their portfolios overlap 0.0%: 0 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Invesco India Financial Services Fund | Invesco India Pharma and Healthcare Fund |
|---|---|---|
| Fund house | Invesco Mutual Fund | Invesco Mutual Fund |
| Category | Sectoral | Sectoral |
| AUM | ₹1,789 Cr (30-09-2026) | ₹436 Cr (30-09-2026) |
| NAV | ₹166.82 (Direct) | ₹9.66 (Direct) |
| Expense ratio (Direct) | 0.96% | 3.30% |
| Expense ratio (Regular) | 2.18% | 5.19% |
| Riskometer | Very High | Very High |
| Benchmark | Nifty Financial Services TRI | BSE Healthcare TRI |
| Launch date | 14-07-2008 | 01-09-2026 |
| Minimum investment | Not available | Not available |
| Lock in | None | None |
| Fund managers | Hiten Jain, Haresh Kapoor | Aditya Khemani |
| Exit load | Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year. | Exit load of 0.50%, if redeemed within 3 months. |
Invesco India Financial Services vs Invesco India Pharma and Healthcare: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Invesco India Financial Services Fund (Direct) | −0.67% | −5.87% | −1.64% | −2.22% | +15.03% | +12.58% | +14.83% |
| Invesco India Pharma and Healthcare Fund (Direct) | +0.73% | -- | -- | -- | -- | -- | -- |
| Sectoral average | −1.70% | -- | -- | -- | -- | -- | -- |
Category average: the average of the 20 Sectoral funds, same plan type.
Invesco India Financial Services vs Invesco India Pharma and Healthcare: Year-wise Returns
| Year | Financial ServicesInvesco India Financial Services | Pharma and HealthcareInvesco India Pharma and Healthcare |
|---|---|---|
| 2026to date | −4.74% | -- |
| 2025 | +16.58% | -- |
| 2024 | +21.45% | -- |
| 2023 | +27.66% | -- |
| 2022 | +14.38% | -- |
| 2021 | +15.62% | -- |
Invesco India Financial Services vs Invesco India Pharma and Healthcare: Rolling Returns
Every holding period of both funds, against Nifty Financial Services TRI, the benchmark of Invesco India Financial Services Fund
Invesco India Financial Services vs Invesco India Pharma and Healthcare: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Invesco India Financial Services Fund (Direct) | Invesco India Pharma and Healthcare Fund (Direct) |
|---|---|---|
| Return (CAGR) | +14.95% | −23.45% |
| Standard deviation | 19.99% | 18.70% |
| Sharpe ratio | 0.45 | -1.54 |
| Sortino ratio | 0.62 | -2.20 |
| Maximum drawdown | −42.4% (23-03-2020) | −11.4% (23-10-2026) |
| Beta | 0.91 | 1.00 |
| Alpha | +2.67% | −8.00% |
From daily NAVs, 02-01-2013 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Invesco India Financial Services Fund (Direct)
Invesco India Pharma and Healthcare Fund (Direct)
Nifty Financial Services TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Invesco India Financial Services Fund (Direct) | −7.3% | 10-09-2026 | 23-10-2026 | Not yet | -- | −5.4% |
| Invesco India Pharma and Healthcare Fund (Direct) | −11.4% | 23-09-2026 | 23-10-2026 | Not yet | -- | −4.4% |
| Nifty Financial Services TRI | −4.9% | 23-09-2026 | 27-10-2026 | Not yet | -- | −3.3% |
From daily values since 10-09-2026, the first day every fund has.
Invesco India Financial Services vs Invesco India Pharma and Healthcare: Portfolio Overlap
From each fund's latest monthly portfolio: Invesco India Financial Services Fund, September 2026; Invesco India Pharma and Healthcare Fund, September 2026
Holdings in common
- Overlap
- 0.0%
- Held by both
- 0
- Only in Invesco India Financial Services
- 34
- Only in Invesco India Pharma and Healthcare
- 13
Overlap: for each holding both funds own, the smaller of its two weights, added up. 0.0% means 0.0% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Invesco India Financial Services Fund
| Security | % of fund |
|---|---|
| ICICI Bank Limited | 12.84% |
| Axis Bank Limited | 6.95% |
| HDFC Bank Limited | 5.98% |
| Karur Vysya Bank Limited | 5.13% |
| Multi Commodity Exchange of India Limited | 4.63% |
Largest holdings only in Invesco India Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Max Healthcare Institute Limited | 9.58% |
| Sun Pharmaceutical Industries Limited | 8.99% |
| Sai Life Sciences Limited | 8.63% |
| Apollo Hospitals Enterprise Limited | 8.03% |
| Manipal Health Enterprises Ltd | 7.98% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Invesco India Financial Services | Invesco India Pharma and Healthcare |
|---|---|---|
| Equity | 95.7% | 87.0% |
| Debt | 0.0% | 0.0% |
| Cash and others | 4.3% | 13.0% |
Market cap of stocks
| Market cap | Invesco India Financial Services | Invesco India Pharma and Healthcare |
|---|---|---|
| Large Cap | 53.8% | 29.8% |
| Mid Cap | 15.6% | 16.4% |
| Small Cap | 24.2% | 32.8% |
| Not on AMFI's list | 2.2% | 8.0% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Invesco India Financial Services | Invesco India Pharma and Healthcare |
|---|---|---|
| Healthcare Services | 0.0% | 45.6% |
| Banks | 45.3% | 0.0% |
| Pharmaceuticals & Biotechnology | 0.0% | 41.4% |
| Capital Markets | 26.1% | 0.0% |
| Finance | 17.0% | 0.0% |
| Insurance | 5.5% | 0.0% |
| Financial Technology (Fintech) | 1.9% | 0.0% |
The six largest sectors of each fund's stocks, % of the fund.
Invesco India Financial Services vs Invesco India Pharma and Healthcare: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Invesco India Financial Services Fund | Invesco India Pharma and Healthcare Fund |
|---|---|---|
| Total expense ratio (Direct) | 0.96% | 3.30% |
| Base expense ratio (Direct) | 0.71% | 0.50% |
| Total expense ratio (Regular) | 2.18% | 5.19% |
| Base expense ratio (Regular) | 1.78% | 2.10% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare Invesco India Financial Services with
Invesco India Financial Services Fund vs Invesco India Pharma and Healthcare Fund: Frequently Asked Questions
What is the difference between Invesco India Financial Services Fund and Invesco India Pharma and Healthcare Fund?
Invesco India Financial Services Fund is a Sectoral fund, Invesco India Pharma and Healthcare Fund is a Sectoral fund, run by Invesco Mutual Fund. Their portfolios overlap 0.0%. Invesco India Financial Services Fund charges 0.96% a year and Invesco India Pharma and Healthcare Fund 3.30%.
Which has the lower expense ratio, Invesco India Financial Services Fund or Invesco India Pharma and Healthcare Fund?
Invesco India Financial Services Fund charges less: 0.96% a year against 3.30%. These are the Direct plans' total expense ratios reported to AMFI.
How much do Invesco India Financial Services Fund and Invesco India Pharma and Healthcare Fund overlap?
0.0%. They hold 0 of the same securities. From each fund's latest monthly portfolio.
Which is riskier, Invesco India Financial Services Fund or Invesco India Pharma and Healthcare Fund?
On SEBI's riskometer, Invesco India Financial Services Fund is rated Very High and Invesco India Pharma and Healthcare Fund Very High. Over their common history, the standard deviation of daily returns was 19.99% and 18.70% a year.
Can I invest in both Invesco India Financial Services Fund and Invesco India Pharma and Healthcare Fund?
Yes. 0.0% of each fund's money sits in the same holdings, so the two hold mostly different investments.
Who manages Invesco India Financial Services Fund and Invesco India Pharma and Healthcare Fund?
Invesco India Financial Services Fund: Hiten Jain, Haresh Kapoor. Invesco India Pharma and Healthcare Fund: Aditya Khemani.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.